Expect the same funds to run the shares up the flagpole as the comps change. Study the one year chart and note every major fund added the entire way down as shorts exited
I recall this issue being $1.40 in Feb. So what the hell are you talking about day trader ?
It took tutes four years to gain 6%
They waill never get retail to sell
That logic as you say is doing damage thats impossible to calculate. Its killing biotech
We estimate ARNA has the cash to make it through 2017 However they will see at least two windfalls this year via partnerships that are known to be initiated within the industry
Sentiment: Strong Buy